CNano Receives Regulatory Approval from EPA to Sell Multi-Wall Carbon Nanotubes

CNano Technology Limited (CNano) announced that it has received regulatory approval from the U.S. Environmental Protection Agency (EPA) to sell multi-wall carbon nanotubes (MWNTs) through its subsidiary in the USA. This approval of consent order places CNano on the short list of manufacturers approved to supply MWNTs in the United States under the strict nanotechnology regulations of the EPA. The approval results from the Pre-Manufacturing Notice (PMN) filed by CNano for the MWNTs produced at its 500 tons per year facility in Beijing, China.

"We are pleased that our cooperative effort with the EPA resulted in a timely regulatory approval. With the recent manufacturing capacity expansion giving us the largest MWNT manufacturing capacity in the world, CNano is committed to be a global supplier of these MWNTs in compliance with applicable regulations," noted Xindi Wu, President and CEO of CNano Technology. "We have been working on a developmental scale with many North American companies and the EPA approval gives us the green light to complete commercialization leading to early sales," added Xindi Wu.

The growing list of commercial applications for carbon nanotubes includes conductive plastics for electronics and automotive, structural composites for sporting goods and aerospace, conductive coatings for electronics and aerospace, electrodes for batteries, super capacitors and fuel cells among others.

CNano also joined EPA's Nanomaterials Stewardship Program with in-depth participation to work with the agency and other nano materials manufacturers from submission to development of information including risk management practices for nanoscale materials.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.